Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Wanbangde Pharmaceutical Holding Group Co., Ltd.
  6. Summary
    002082   CNE000001P94

WANBANGDE PHARMACEUTICAL HOLDING GROUP CO., LTD.

(002082)
  Report
 SummaryChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
10.59 10.54 10.42 10.19 10.12 Last
1203080 866200 1038547 1055900 712602 Volume
0.00% -0.47% -1.14% -2.21% -0.69% Change
Estimated financial data (e)
Sales 2019 16 691 M 2 612 M 2 612 M
Net income 2019 295 M 46,1 M 46,1 M
Net Debt 2019 762 M 119 M 119 M
P/E ratio 2019 16,0x
Yield 2019 1,59%
Sales 2020 13 702 M 2 145 M 2 145 M
Net income 2020 285 M 44,6 M 44,6 M
Net Debt 2020 1 301 M 204 M 204 M
P/E ratio 2020 29,1x
Yield 2020 1,46%
Capitalization 6 223 M 975 M 974 M
EV / Sales 2019 0,18x
EV / Sales 2020 0,71x
Nbr of Employees 2 744
Free-Float 34,0%
More Financials
Company
Wanbangde Pharmaceutical Holdings Group Co Ltd, formerly Wanbangde New Building Materials Co Ltd, is a China-based company mainly engaged in aluminum processing business and medical device business. The Company mainly provides aluminum ingots, aluminum rods, aluminum profiles, aluminum plates, powder coatings, medical equipment and other products. The Company is also engaged in copper and zinc trade, aluminum... 
Sector
Aluminum
Calendar
10/27Earnings Release
More about the company
All news about WANBANGDE PHARMACEUTICAL HOLDING GROUP CO., LTD.
10/07Tranche Update on Wanbangde Pharmaceutical Holding Group Co., Ltd.'s Equity Buyback Pla..
CI
09/20WANBANGDE PHARMACEUTICAL HOLDING GRO : 002082) added to S&P Global BMI Index
CI
08/25Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Half ..
CI
07/01Tranche Update on Wanbangde Pharmaceutical Holding Group Co., Ltd.'s Equity Buyback Pla..
CI
05/25Wanbangde Pharmaceutical Holding Group Co., Ltd. Announces 2020 Final Profit Distributi..
CI
05/19Wanbangde Pharmaceutical Holding Group Co., Ltd. Approves Dividend for the Year 2020
CI
04/28Wanbangde Pharmaceutical Holding Group Co., Ltd. Proposes Final Cash Dividend for 2020
CI
04/28Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the First..
CI
04/27Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Full ..
CI
04/05Tranche Update on Wanbangde Pharmaceutical Holding Group Co., Ltd.'s Equity Buyback Pla..
CI
03/15Wanbangde Pharmaceutical Holding Group Co., Ltd. authorizes a Buyback Plan.
CI
03/14Wanbangde Pharmaceutical Holding Group Co., Ltd. announces an Equity Buyback for CNY 10..
CI
03/01Huzhou Wanbangde Investment Co., Ltd. completed the acquisition of 100% stake in Dongli..
CI
02/01Chinese syringe producers under pressure as vaccination programmes drive order surge
RE
2020Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Nine ..
CI
More news
News in other languages on WANBANGDE PHARMACEUTICAL HOLDING GROUP CO., LTD.

- No features available -

More news
Chart WANBANGDE PHARMACEUTICAL HOLDING GROUP CO., LTD.
Duration : Period :
Wanbangde Pharmaceutical Holding Group Co., Ltd. Technical Analysis Chart | 002082 | CNE000001P94 | MarketScreener
Technical analysis trends WANBANGDE PHARMACEUTICAL HOLDING GROUP CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Managers and Directors
Shou Ming Zhao Chairman & General Manager
Jun Hui Zhao Chief Financial Officer & Director
Hu Gen Wang Chairman-Supervisory Board
Yong Quan Li Independent Director
Yue Cao Independent Director